Effective Papers: Research Paper on Psychoactive Drugs.
The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. View research paper.
Select a psychoactive drug that is of pharmacological interest to you, but not one you will review as part of your Critical Review. For this paper, you may choose drugs of abuse; however, the paper must focus on the pharmacology of the drug and not on the social or addictive aspects.
Through a systematic analysis of medical-scientific literature and online resources (e.g., websites, drug fora, and chat-rooms), the aim of the present paper was to provide an initial comprehensive review of the pharmacology, metabolism, toxicity, and psychoactive effects of the 25C-NBOMe compound, namely, 2-(4-chloro-2,5-dimethoxyphenyl)-N-((2.
The drug may also bind to serotonin 5-HT1A and 5-HT1B receptors. Lobos M, Borges Y, Gonzalez E, Cassels BK. The action of the psychoactive drug 2C-B on isolated rat thoracic aorta. Gen Pharmacol. 1992 Nov;23(6):1139-42.
Psychoactive drugs on the other hand refer to chemical substances that affect the functioning of the brain making an individual exhibit change in behavior, consciousness and the mood. Psychoactive drugs have been a cause of debate in the US due to the fact that the drug can be used therapeutically to treat physical and psychological disorders.
Research indicates that the use of psychoactive drugs such as cannabis facilitates the compelling and protection of treatment for various mental disorders, delays the transition from uneasiness and pressure to Parkinson's disease and Alzheimer's dementia, even though the Food and Drug Administration has not endorsed marijuana for such use.
To date, there are five large and important areas of research that have been either neglected: (1) the sequence of drugs used and the development of different drug-using patterns; (2) the individual, group, and cultural factors influencing low-risk and high-risk outcomes among equivalent drug users; (3) the changing attitudes of both users and.